Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01335360 · ClinicalTrials.gov registry record
Pharmacokinetic Evaluation of Changes in Nevirapine AUC Due to Differences in Weight
A clinical trial, sponsored by Western University of Health Sciences.
- Completed
- Registry status
- 21
- Enrollment target
NCT01335360 is a clinical trial that has completed, run by Western University of Health Sciences. The registered enrollment target is 21 participants.
The verdict
NCT01335360 has completed, sponsored by Western University of Health Sciences.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
This study would be a prospective cohort study, stratified by weight. Patients who are stable on nevirapine for at least 3 months prior to study entry, but no more than 1year will be recruited. For 1 week, subjects will take their morning dose of nevirapine in the clinic (and be observed taking it), and given their evening dose to take at home. Subjects will need to record the date and time they take their evening dose. At the end of the week, the subjects will be sequestered at the clinic for blood draws for a 12hr pharmacokinetic sampling. They will not be brought back in at 24hrs as they will need to be redosed after 12hrs. They will have Liver Function Tests (LFT's) and other labs drawn at study entry, and one month after the end of study. Pharmacokinetic levels will be analyzed using standard mathematical models, and Area Under the Curve (AUC), Maximum concentration (Cmax), and Minimum Concentration (Cmin) will be compared between groups.
Interventions
- DRUG Nevirapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2003-05 |
| Est. Completion | 2003-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01335360
The ClinicalTrials.gov registry entry for NCT01335360 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Western University of Health Sciences, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nevirapine is the first listed.
NCT01335360 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01335360 about?
NCT01335360 is a clinical study titled "Pharmacokinetic Evaluation of Changes in Nevirapine AUC Due to Differences in Weight". This study would be a prospective cohort study, stratified by weight. Patients who are stable on nevirapine for at least 3 months prior to study entry, but no more than 1year will be recruited. For 1 week, subjects will take their morning dose of nevirapine in the clinic (and be observed taking it),...
What is the current status of trial NCT01335360?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2003-05. Estimated completion is 2003-06.
What interventions are being tested in trial NCT01335360?
The interventions under investigation include: Nevirapine (DRUG).
Who is sponsoring clinical trial NCT01335360?
This trial is sponsored by Western University of Health Sciences, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.